TrialScience translational medicine2014

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

Anastasia Papadopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.